Aegerion Pharmaceuticals, Inc.
101 Main Street
Suite 1850
Cambridge
Massachusetts
02142
United States
Tel: 617-500-7867
Fax: 908-541-1155
Website: http://www.aegerion.com/
Email: info@aegerion.com
219 articles about Aegerion Pharmaceuticals, Inc.
-
Aegerion Pharmaceuticals, Inc. Files Registration Statement for Proposed Offering of Common Stock
6/17/2011
-
Aegerion Pharmaceuticals, Inc. Holds Pre-NDA Meeting With FDA for Investigational Lomitapide and is on Track for NDA Submission
6/16/2011
-
Aegerion Pharmaceuticals, Inc. Announces Phase III 56-Week Data in HoFH Patients Taking Investigational Lomitapide is Consistent With 26-Week Data
5/31/2011
-
Aegerion Pharmaceuticals, Inc. Announces First-Quarter 2011 Financial Results
4/28/2011
-
Aegerion Pharmaceuticals, Inc. Appoints Mark J. Fitzpatrick as Chief Financial Officer
4/27/2011
-
Aegerion Pharmaceuticals, Inc. Announces Issuance of Patent for Treating Diseases Associated With Hyperlipidemia and Hypercholesterolemia Using Lomitapide
4/27/2011
-
Aegerion Pharmaceuticals, Inc. to Present at the Deutsche Bank Securities 36th Annual Healthcare Conference
4/26/2011
-
Aegerion Pharmaceuticals, Inc. to Announce First-Quarter 2011 Financial Results on Thursday, April 28
4/20/2011
-
Aegerion Pharmaceuticals, Inc. Announces Appointment of Sol J. Barer, Ph.D. to Board of Directors
4/19/2011
-
Aegerion Pharmaceuticals, Inc. Acknowledges the National Lipid Association's Revised Guidelines for the Treatment of Familial Hypercholesterolemia
4/14/2011
-
Aegerion Pharmaceuticals, Inc. to Present at the 10th Annual Needham Healthcare Conference
3/31/2011
-
FDA Grants 'Orphan Drug' Status to Aegerion Pharmaceuticals, Inc. Drug
3/16/2011
-
FDA Grants Orphan Drug Designation to Aegerion Pharmaceuticals, Inc.' Drug Candidate, Lomitapide, for Treatment of Familial Chylomicronemia
3/15/2011
-
Aegerion Pharmaceuticals, Inc. Announces Fourth-Quarter and Year-End 2010 Financial Results
3/2/2011
-
Aegerion Pharmaceuticals, Inc. Observes Rare Disease Day 2011
2/28/2011
-
Aegerion Pharmaceuticals, Inc. to Announce Fourth-Quarter and Full-Year 2010 Financial Results on Wednesday, March 2
2/24/2011
-
Aegerion Pharmaceuticals, Inc. Appoints Diane L. Tribble, Ph.D., M.M.Sc., as Chief Scientific Officer
2/15/2011
-
Aegerion Pharmaceuticals, Inc. to Present at the Leerink Swann and Company Hot Topics in Therapeutics Roundtable Conference
2/8/2011
-
Aegerion Pharmaceuticals, Inc. Appoints Martha J. Carter as Chief Regulatory Officer
2/7/2011
-
Aegerion Pharmaceuticals, Inc. Unveils New Corporate Identity and Website
1/10/2011